111 Inc ADR (YI)
0.8304  +0.0504 (6.46%)

111 Inc is a leading digital healthcare platform in China that focuses on providing a range of healthcare services through its online and offline ecosystems. The company connects patients with medical resources, pharmacies, and various health service providers, facilitating access to pharmaceuticals, health products, and healthcare information. By leveraging advanced technology and data analytics, 111 Inc aims to enhance the efficiency of the healthcare supply chain and promote better health outcomes for individuals and communities. Its comprehensive approach not only supports consumer needs but also collaborates with healthcare professionals and organizations to drive innovation within the healthcare sector.

SummaryNewsPress ReleasesChartHistorical
Earnings Scheduled For November 27, 2024benzinga.com
Via Benzinga · November 27, 2024
YI Stock Earnings: 111 Reported Results for Q1 2024investorplace.com
111 just reported results for the first quarter of 2024.
Via InvestorPlace · May 23, 2024
YI Stock Earnings: 111 Reported Results for Q4 2023investorplace.com
111 just reported results for the fourth quarter of 2023.
Via InvestorPlace · March 21, 2024
Top 4 Defensive Stocks That Could Lead To Your Biggest Gains This Quarterbenzinga.com
The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.
Via Benzinga · December 28, 2023
Earnings Scheduled For November 30, 2023benzinga.com
Companies Reporting Before The Bell • 111 (NASDAQ:YI) is projected to report earnings for its third quarter. • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.45 per share on revenue of $249.41 million.
Via Benzinga · November 30, 2023
111 Clocks 24% Revenue Growth In Q1benzinga.com
111 Inc (NASDAQ: YI) reported a Q1 2023 net revenues increase of 23.9% Y/Y to ¥3.7 billion ($538.3 million), representing the 19th consecutive 
Via Benzinga · June 15, 2023
Earnings Scheduled For March 21, 2024benzinga.com
Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per share on revenue of $16.47 million.
Via Benzinga · March 21, 2024
3 Top M&A Plays: Lucrative Merger Deals Poised for Big Payoffsinvestorplace.com
Are you looking for the top M&A plays for big payoffs? Here are three lucrative merger deals poised for big payoffs.
Via InvestorPlace · November 23, 2023
Stocks That Hit 52-Week Lows On Wednesdaybenzinga.com
  On Wednesday, 216 stocks hit new 52-week lows.
Via Benzinga · May 18, 2022
This Online Healthcare Company Continues Its Winning Stride In Q2, Deal With Tencent A Cherry On The Cakebenzinga.com
111 Inc (NASDAQ: YI) reported a Q2 FY23 net revenue increase of 14.5% Y/Y to 
Via Benzinga · August 24, 2023
Earnings Scheduled For March 23, 2023benzinga.com
Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is likely to report earnings for its fourth quarter.
Via Benzinga · March 23, 2023
Charter Communications, Braze And Some Other Big Stocks Moving Lower In Today's Pre-Market Sessioncharter-com
U.S. stock futures traded slightly higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. iQIYI, Inc. (NASDAQ: IQ) shares dipped 14.1% to $3.31 in pre-market trading after gaining over 9% on Tuesday.
Via Benzinga · December 14, 2022
Why Vallon Pharmaceuticals Shares Are Trading Higher By Over 150%; Here Are 29 Stocks Moving Premarketbenzinga.com
Gainers Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares rose 150.9% to $0.6313 in pre-market trading after the company entered into a definitive merger agreement with GRI Bio.
Via Benzinga · December 14, 2022
10 Consumer Staples Stocks Moving In Tuesday's Pre-Market Sessionbenzinga.com
Via Benzinga · December 13, 2022
Procter & Gamble, Anheuser-Busch InBev And Other Most Overbought Stocks In Consumer Staples Sectorbenzinga.com
The most overbought stocks in the consumer staples sector presents an opportunity to go short on these overvalued companies. Here’s the latest list of major overbought players in this sector.  
Via Benzinga · December 12, 2022
Why Top Ships Shares Are Trading Lower By Over 60%; Here Are 24 Stocks Moving Premarketbenzinga.com
Gainers Cosmos Holdings Inc. (NASDAQ: COSM) shares rose 18.1% to $0.6316 in pre-market trading after jumping over 34% on Friday. Cosmos Holdings, last month, posted Q3 loss of $0.08 per share.
Via Benzinga · December 5, 2022
Why Harpoon Therapeutics Shares Are Trading Higher By 97%? Here Are 53 Stocks Moving In Monday's Mid-Day Sessionbenzinga.com
Gainers HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) shares jumped 165.7% to $1.4350 after jumping around 118% on Friday. HTG Molecular Diagnostics, last month, posted a Q3 loss of $0.41 per share.
Via Benzinga · December 12, 2022
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Mondayinvestorplace.com
The biggest pre-market stock movers for Monday include many Chinese shares that traders will want to keep an eye on today!
Via InvestorPlace · December 5, 2022
Earnings Scheduled For December 1, 2022benzinga.com
Companies Reporting Before The Bell • 111 (NASDAQ:YI) is expected to report earnings for its third quarter.
Via Benzinga · December 1, 2022
Earnings Scheduled For June 16, 2022benzinga.com
  Companies Reporting Before The Bell • Commercial Metals (NYSE:CMC) is expected to report quarterly earnings at $1.98 per share on revenue of $2.41 billion.
Via Benzinga · June 16, 2022
Stocks That Hit 52-Week Lows On Mondaybenzinga.com
  On Monday, 149 companies reached new 52-week lows.
Via Benzinga · May 23, 2022
Earnings Scheduled For August 25, 2022benzinga.com
  Companies Reporting Before The Bell • Gold Fields (NYSE:GFI) is likely to report earnings for its first quarter. • 111 (NASDAQ:YI) is projected to report earnings for its second quarter.
Via Benzinga · August 25, 2022
74 Biggest Movers From Yesterdaybenzinga.com
Gainers
Via Benzinga · June 3, 2022
70 Biggest Movers From Fridaybenzinga.com
Gainers Avadel Pharmaceuticals plc (NASDAQ: AVDL) shares climbed 133.6% to close at $2.50 on Friday. Avadel Pharmaceuticals shares dipped 68% on Thursday after announcing new FDA request for experimental narcolepsy drug.
Via Benzinga · May 31, 2022
Stocks That Hit 52-Week Lows On Tuesdaybenzinga.com
  On Tuesday, 540 companies set new 52-week lows.
Via Benzinga · May 24, 2022